{"id":"W3101707478","doi":"10.1016/j.annonc.2020.11.001","title":"PARP inhibition in homologous-recombination-deficient early-stage breast cancer","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Radius Health; Merck; AstraZeneca; Pfizer","keywords":"Olaparib; Medicine; Breast cancer; BRCA mutation; PARP inhibitor; Oncology; Internal medicine; Chemotherapy; Cancer; Poly ADP ribose polymerase; Polymerase; Genetics; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002874759,0.0002072763,0.0003222168,0.0001966184,0.0001398985,0.0003834977,0.0003326287,0.000261413,0.001976406],"category_scores_gemma":[0.0001642579,0.0001015009,0.0002151893,0.000270701,0.0001342815,0.0001784831,0.0001181947,0.001021786,0.0003952913],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003015467,"about_ca_system_score_gemma":0.0003176577,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003269668,"about_ca_topic_score_gemma":0.0007528038,"domain_scores_codex":[0.9998986,0.00002037459,0.000006894648,0.00001161348,0.0000219822,0.00004055674],"domain_scores_gemma":[0.9999311,0.00001713126,0.00001495912,0.00001052024,0.000008373612,0.00001798271],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.008486474,0.002487815,0.001967208,0.0006415216,0.000131183,0.0006531038,0.00008556622,0.001790431,0.7905996,0.001860386,0.008114003,0.1831828],"study_design_scores_gemma":[0.001997944,0.02128871,0.03139431,0.00007973488,0.0002675706,0.005529649,0.000185859,0.003532983,0.8636557,0.001026181,0.07100527,0.00003608051],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9398672,0.04288844,0.002624883,0.001152363,0.0004001746,0.0001133233,0.001364522,0.0003222921,0.01126675],"genre_scores_gemma":[0.9815804,0.01147719,0.001199521,0.0001998886,0.00004107004,0.00004126288,0.001017176,0.00001725703,0.004426099],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001976406,"threshold_uncertainty_score":0.006611705,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1140779213665019,"score_gpt":0.40758879029384,"score_spread":0.2935108689273381,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}